Quick Answer
TransMedics Group, Inc. reported Net Income Loss of $190.29 million for the year ending 2025.
- TransMedics Group, Inc. showed an increase of +436.6% in Net Income Loss from 2024 to 2025.
- This data is from TransMedics Group, Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), TransMedics Group, Inc.'s Net Income Loss has grown by 901.0%.
- Historical annual values: Fiscal year 2025: $190.29 million | Fiscal year 2024: $35.46 million | Fiscal year 2023: -$25.03 million | Fiscal year 2022: -$36.23 million | Fiscal year 2021: -$44.22 million | Fiscal year 2020: -$28.75 million | Fiscal year 2019: -$33.55 million | Fiscal year 2018: -$23.76 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: